equityflowunderstand the flow and follow it
EquityFlow › Companies › Tagworks Pharmaceuticals

Tagworks Pharmaceuticals

Biotech · NL

Precision-oncology biotech using Click-to-Release chemistry for targeted ADCs.

In the network

Shares the most investors with (number = shared investors):
Adcendo 2Volta Medical 2

Funding history

DateRoundAmount
Jun 2023Series A
Dutch precision-medicine biotech Tagworks Pharmaceuticals raised a USD65M Series A led by Ysios Capital and Gilde Healthcare, with Novartis Venture Fund, NEA and Lightstone, for its Click-to-Release cancer therapies.
$59.5M

Investors

Tap an investor to see what else they have backed.

Gilde HealthcareLightstone VenturesNew Enterprise AssociatesNovartis Venture FundYsios Capital

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in NL

OurMindNew Dawn BioEddy GridInvisixSeenonsSurebirdBalthazarGroove QuantumLabfreshArceonTebiAquablu

Other companies at Series A stage

&Done&Open011h01Health1000 Satellites100ms11x.ai12 Pharmacy180° Seguros1X Technologies1k Kirana Bazaar207
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.